Embrex Inc is a company that operates in the Biotechnology industry. It employs 11-20 people and has $1M-$5M of revenue.
| Website | http://www.embrex.com |
| Revenue | $60.8 million |
| Employees | 23 (4 on RocketReach) |
| Founded | 1985 |
| Industry | Biotechnology Research, Business Services General, Medical Supplies, Business Services, Drug Discovery |
| Keywords | Biotechnology, Life Sciences, Pharmaceutical, Biomedical, Research, Clinical Trials, Development, Healthcare, Biologics, Medical Technology, Bioengineering, Cell Technology, Genetic Engineering, Molecular Biology, Drug Discovery, Bioprocessing, Biomanufacturing |
| Competitors | Merck Animal Health, Cargill, Boehringer Ingelheim, Zoetis, DSM, Elanco, Alltech, Dechra Pharmaceuticals PLC, Ceva Santé Animale, Vetoquinol Global +22 more (view full list) |
| SIC | SIC Code 283 Companies, SIC Code 73 Companies, SIC Code 28 Companies, SIC Code 737 Companies |
| NAICS | NAICS Code 3254 Companies, NAICS Code 32 Companies, NAICS Code 325412 Companies, NAICS Code 541 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 54 Companies |
Looking for a particular Embrex employee's phone or email?
The Embrex annual revenue was $60.8 million in 2026.
Robin Shyr is the Vice President, Asia of Embrex.
4 people are employed at Embrex.
The NAICS codes for Embrex are [3254, 32, 325412, 541, 32541, 325, 54].
The SIC codes for Embrex are [283, 73, 28, 737].